中生制药:全资收购礼新医药

格隆汇
Jul 15, 2025

中国生物制药在港交所公告称,董事会欣然宣布,于二零二五年七月十五日(交易时段后),本公司(透过买方)全资收购礼新医药,与卖方、礼新医药及Ying Qin Zang订立买卖协议,据此,买方已同意按对价购买而卖方已同意按对价出售礼新医药95.09%股权。于本公告日期,买方持有礼新医药4.91%股权。于交割后,礼新医药将成为本公司间接全资附属公司。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10